Research Outputs (433)

Sort by: Date | Title

10 | 25 | 50 | 100

1/9

A B C D E F G H I K L M N O P Q R S T U V W Β All

A Multicenter Phase 2 Trial of Tumor Treating Fields plus Chemotherapy for First-Line Treatment of Gastric Adenocarcinoma
Li J, Yeo W, Lam KO ( 2020 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1200/JCO.2020.38.4_suppl.TPS474
Baseline liver function and outcomes in the phase III REFLECT study in patients with unresectable hepatocellular carcinoma (uHCC)
Vogel A, Frenette C, Sung MW, Daniele B, Baron AD, Chan SL, Blanc JF, Tamai T, Ren M, Lim HJ, Palmer DH, Takami Y, Kudo M ( 2020 )
JOURNAL OF CLINICAL ONCOLOGY
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1200/JCO.2020.38.4_suppl.524
Changes in physical activity from pre-diagnosis to first 5 years post-diagnosis: a prospective cohort study in Chinese breast cancer patient
Yuanyuan Lei, Winnie Yeo, Suzanne C. Ho, Ashley Chi Kin Cheng, Carol Kwok ( 2020 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1200/JCO.2020.38.15_suppl.e24121
Hepatic adverse events during treatment with immune checkpoint inhibitors (ICI) in cancer patients: A territory-wide patient cohort study
Chan SL, Yip TCF, Wong VWS, Chan AWH, Tong CKK, Tse YK, Yuen BWY, Luk HWS, Lui GCY, Chan HLY, Mok TSK, Wong GLH ( 2020 )
JOURNAL OF CLINICAL ONCOLOGY
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1200/JCO.2020.38.4_suppl.508
Initial lenvatinib therapy with no prior TACE in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and Child-Pugh A liver function: A proof-of-concept study
Kudo M, Ueshima K, Chan SL, Aoki T, Hagiwara S, Minami Y, Ida H, Takenaka M, Watanabe T, Morita M, Ogawa C, Wada Y, Ikeda M, Ishii H, Izumi N, Hiraoka A, Aikata H, Nishida N ( 2020 )
JOURNAL OF CLINICAL ONCOLOGY
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1200/JCO.2020.38.4_suppl.522
Targeting the polycomb repressive complex complex-2 related proteins in nasopharyngeal carcinoma
ZHU JY, Li LL, Hui C, Tong JH, Chan R, Wong CH, Ai QY, Hui P, Chan TC, Lo KW, Tao Q, Ma B ( 2020 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1158/1538-7445.AM2020-2923
Validation of a Chinese-Specific Food Frequency Questionnaire (FFQ) for Assessing Dietary Lignans Intake among Breast Cancer Patients in Hong Kong
HE YQ, Lei YY, Kwok C, Cheng A, Cheung KL, Lee I, Lee R, Ho SC, Yeo W ( 2020 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1158/1538-7445.SABCS19-P2-13-19
Assessment of cancer health literacy among breast cancer patients in Hong Kong
Yeo W, Ng K, Cheung K, Lee I, Suen J, Tong M, Mo F ( 2019 )
BREAST
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/S0960-9776(19)30429-1
Association of adverse events (AEs) with efficacy outcomes for cabozantinib (C) in patients (pts) with advanced hepatocellular carcinoma (aHCC) in the phase III CELESTIAL trial
Abou-Alfa GK, Meyer T, Cheng AL, Cicin I, Bolondi L, Klumpen HJ, Chan SL, Dadduzio V, Milwee S, Dubey S, Kelley RK, El-Khoueiry AB ( 2019 )
JOURNAL OF CLINICAL ONCOLOGY
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.4088
Enhancer reprogramming by selective HDAC8 inhibition potentiates tumor remission and durable benefit by PD-L1 blockade
Weiqin YANG, Yu FENG, Jingying ZHOU, Otto K.W. CHEUNG, Feng WU, Zhiwu TAN, Liangliang XU, Hanyong SUN, Yuan TIAN, Stephen L. CHAN, Anthony W.H. CHAN, Zhiwei CHEN, Kevin Y.L. YIP, Ka-Fai TO, Joseph J.Y. SUNG, Alfred S.L. CHENG ( 2019 )
Refereed conference paper presented and published in conference proceedings
Hepatic Adverse Events of Immune Checkpoint Inhibitors - A Territory-Wide Cohort Study
Wong GL, Wong VWS, Tong CKK, Tse YK, Yip TCF, Chan HLY, Chan SL ( 2019 )
HEPATOLOGY
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1002/hep.30941
Institutional-based prospective molecular profiling of advanced solid tumours in Hong Kong: A report of 253 cases
Loong H, Chow C, Ho K, Fung J, Koh J, Chan TC, Leung LK S, Yeo W, Ma B, Chan S L, Hui EP, Lee KWC, Wong ACY, Lam DCM, Wong KCW, Mok ST, To KF ( 2019 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdz431.006
Intratumoural MDSC recruitment by chemotherapeutic agent, 5-FU offsets the anti-tumor activity of immune-checkpoint inhibitor in HCC
Kwong TT, Wong CH, Zhou JY, Cheng ASL, Chan AWH, Chan SL ( 2019 )
ANNALS OF ONCOLOGY
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdz452.021
Molecular profiling of non-small cell lung cancer (NSCLC) in Asia with targeted next-generation sequencing (NGS): Interim analysis of a co-operative group study (ATORG-001)
A.C. Tan, H. Loong, G.F. Ho, A. Seet, B. Chiam, D.Q. Cheah, G.S. Tan, K.H. Lim, J.C-H. Yang, T.S.K. Mok, D-W. Kim, D.S.W. Tan ( 2019 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdz431.010
Outcomes based on albumin-bilirubin (ALBI) grade in the phase III CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC)
Chan SL, Miksad R, Cicin I, Chen Y, Klumpen HJ, Kim S, Lin ZZ, Youkstetter J, Sen S, Cheng AL, El-Khoueiry AB, Meyer T, Kelley RK, Abou-Alfa GK ( 2019 )
ANNALS OF ONCOLOGY
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdz422.005
Prospective 36-month follow-up to determine changes in body mass index and weight among Chinese breast cancer survivors
W Yeo, YY Lei, AC Cheng, CC Kwok, KL Cheung, R Lee, IC Lee, YQ He, S Ho ( 2019 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1158/1538-7445.SABCS18-P1-12-07
A feasibility study to evaluate the relationships between endocrine symptoms, drug adherence and genetic polymorphisms in breast cancer patients receiving tamoxifen therapy
Chan C. W. H., Alexandra McCarthy A., Chan J. Y. W., Chow K. M., Waye M. M.Y., Tsui S. K. W., Yeo W., Choi K. C., So W. K. W., Soo W., Miaskowski C. ( 2018 )
Refereed conference paper presented and published in conference proceedings
Bone health in premenopausal Chinese patients after adjuvant chemotherapy for early breast cancer
W Yeo, GS Liem, J Suen, E Pang, R Ng, CHW Yip, FKF Mo ( 2018 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/S0959-8049(18)30379-4
Changes in body weight over 18-months follow-up among Chinese patients after breast cancer diagnosis
Yeo W, Lei YY, Cheng AC, Kwok CC, Cheung KL, Lee IC, Lee R, Ho S ( 2018 )
ANNALS OF ONCOLOGY
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdy270.251
Dietary soy intake and mortality outcome in Chinese breast cancer survivors
Ho S, Yeo W, Cheng ACK, Kwok CCH, Lee R, Lee ICK, Cheung CKL, Sham A, Ip A, Lei YY, He YQ ( 2018 )
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
Refereed conference paper presented and published in conference proceedings
Efficacy and Safety of Nivolumab in Asian Patients With Advanced Hepatocellular Carcinoma (HCC): Subanalysis of the CheckMate 040 Study
Amy Ma, Su-Pin Choo, Chiun Hsu, Yoon-Koo Kang, Ming-Mo Hou, Winnie Yeo, Kazushi Numata, Akhil Chopra, Adyb Baakili, Christine dela Cruz, Huanyu Zhao, Masatoshi Kudo ( 2018 )
Refereed conference paper presented and published in conference proceedings
Enhancing the efficacy of liver cancer immunotherapy by specific inhibition of histone deacetylase 8
Weiqin YANG, Jingying ZHOU, Yu FENG, Hangyong SUN, Stephen L CHAN, Anthony W.H. CHAN, Zhiwei CHEN, Ka-Fai TO, Alfred Sze-Lok CHENG ( 2018 )
Refereed conference paper presented and published in conference proceedings
Hepatic safety and biomarker assessments in sorafenib-experienced patients with advanced hepatocellular carcinoma treated with nivolumab in the CheckMate-040 study
Tim Meyer, Ignacio Melero, Thomas Yau, Chiun Hsu, Masatoshi Kudo, Su-Pin Choo, Jörg Trojan, Theodore H. Welling, Yoon-Koo Kang, Winnie Yeo, Akhil Chopra, Adyb Baakili, Christine dela Cruz, Huanyu Zhao, Jaclyn Neely, odd S. Crocenzi, Anthony B. El-Khoueiry, Bruno Sangro ( 2018 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/S0168-8278(18)30249-6
Longitudinal study on incidences of obesity and weight changes in Chinese patients with early-stage breast cancer
Yeo W, Lei YY, Cheng AC, Kwok CC, Cheung KL, Lee R, Lee IC, He YQ, Ho S ( 2018 )
ANNALS OF ONCOLOGY
Refereed conference paper presented and published in conference proceedings
Stereotactic body radiotherapy (SBRT) versus conventional fractionated intensity-modulated radiotherapy (CF-IMRT) for Asian patients with early-stage localized prostate cancer: Acute toxicity results from a prospective randomized phase II study
Poon DM, Lam D, Wong K, Mok F, Mo F, Chu CM, Ng ACF, Suen J, Chan ATC ( 2018 )
ANNALS OF ONCOLOGY
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdy434.006
Superior efficacy and long-term survival benefit of HDAC8 and PD-L1 co-blockade in liver cancer immunotherapy
Alfred Sze Lok CHENG, Weiqin YANG, Jingying ZHOU, Yu FENG, Hanyong SHUN, Stephen L. CHAN, Zhiwei CHEN, Ka-Fai TO, Joseph J. SUNG ( 2018 )
Refereed conference paper presented and published in conference proceedings
A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)
Chan ATC, Hui EP, Ngan RKC, Tung SY, Cheung ACK, Ng WT, Lee VHF, Ma B, Cheng HC, Wong CS, Loong HHF, Tong M, Poon DMC, Ahuja A, King AD, Wang K, Mo F, Zee BCY, Chan AKC, Lo DYM ( 2017 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.6002
A Phase I/II study everolimus in combination with paclitaxelcarboplatin in patients with advanced adenocarcinoma of the stomach. Annals of Oncology 2017, #402P
H.H. Loong, F. Mo, L. Li, C. Lee, K-C. Lam, J. Koh, P. Chiu, A. Teoh, A.T.C. Chan, E. Ng, W. Yeo ( 2017 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdx367.035
A preclinical study of the combined treatment of arginase and canavanine in pancreatic cancer
TT Kwong, CH Wong, HH Loong, Stephen L Chan ( 2017 )
Refereed conference paper presented and published in conference proceedings
Biomarker analysis of the multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)
Edwin Pun Hui, Anthony T. C. Chan, Roger K.C. Ngan, Stewart Yuk Tung, Ashley Chi Kin Cheng, Wai Tong Ng, Victor HF Lee, Brigette Ma, Hoi Ching Cheng, Frank C.S. Wong, Herbert H. F. Loong, Macy Tong, Daren MC Poon, Anil Tejbhan Ahuja, Ann Dorothy King, Ki Wang, Frankie Mo, Benny C.Y. Zee, Allen K.C. Chan, YM Dennis Lo ( 2017 )
Refereed conference paper presented and published in conference proceedings
Efficacy and safety of nivolumab in patients with advanced hepatocellular carcinoma analyzed by patient age: A sub-analysis of the CheckMate 040 study.
Melero Ignacio, El-Khoueiry Anthony, Yau Thomas, Hsu Chiun, Kudo Masatoshi, Crocenzi Todd, Kim Tae-You, Choo Su-Pin, Trojan Jo¨ rg, Welling Theodore, Kang Yoon-Koo, Yeo Winnie, Chopra Akhil, Baakili Adyb, dela Cruz Christine, Zhao Huanyu, Sangro Bruno, Meyer Tim ( 2017 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdx262.007
Granulin-Epithelin Precursor And ATP-Dependent Binding Cassette (ABC)B5 Regulate Liver Cancer Cell Response To Transarterial Chemoembolisation (TACE) After Curative Hepatectomy
Charing CN Chong, ST Cheung, Yue-sun Cheung, Kit-fai Lee, John Wong, Clement CM Chu, Anthony KW Fong, Andrew KY Fung, Hon-ting Lok, Simon CH Yu, Stephen L Chan, Paul BS Lai ( 2017 )
Refereed conference paper presented and published in conference proceedings
Microwave Ablation Provided Better Overall Survival Than Liver Resection For Small Hepatocellular Carcinoma In Patients With Borderline Liver Function
Charing C.N. Chong, Kit-Fai Lee, Cheuk-Man Chu, Anthony W.H. Chan, John Wong, Stephen L. Chan, Andrew Fung, Anthony Fong, Sunny Y.S. Cheung, Simon C.H. Yu, Paul B.S. Lai ( 2017 )
Refereed conference paper presented and published in conference proceedings
Preclinical study on the efficacy of Panobinostat (LBH589) in hepatocellular carcinoma (HCC)
CT Choy, WY Man, CH Wong, Stephen L Chan ( 2017 )
Refereed conference paper presented and published in conference proceedings
Significant changes in dietary intake and physical activity after breast cancer diagnosis in a Chinese breast cancer cohort study
Y. Lei, W. Yeo, S.C. Ho, C-K.I. Lee, K.L. Cheung, R. Lee, Y-Q. He ( 2017 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdx362.057
Amide proton transfer (APT) imaging in head and neck cancer: preliminary results'
LAW King Hong Benjamin, KING Ann Dorothy, BHATIA Kunwar Suryaveer Singh, AHUJA Anil Tejbhan, MA Buig Yue Brigette, YEUNG Kw David, WANG Yixiang, YUAN Jing ( 2016 )
24th ISMRM Annual Meeting and Exhibition
Refereed conference paper presented and published in conference proceedings
Axitinib in recurrent or metastatic nasopharyngeal carcinoma (NPC): final result of a phase 2 clinical trial with pharmacokinetic (PK) correlation
Hui EP, Ma BB, Mo F, Kam MK, Chan SL, Loong HH, Ho R, Leung SF, King AD, Wang K, Ahuja A, Chan CM, Hui CW, Wong CH, Chan ATC. ( 2016 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdw 376.13
Changes in cardiovascular risk profiles among young Chinese patients with breast cancer after adjuvant chemotherapy (European Journal of Cancer 57, suppl. 2 (2016)S134)
YEO Winnie, MO Kwok Fai, SUEN J, PANG Elizabeth Summing, YIP C, LEE K, LIEM G ( 2016 )
Refereed conference paper presented and published in conference proceedings
Homing and engraftment of human hematopoietic stem/progenitor cells are regulated by R4 RGS family proteins
Wong YT, Li CK, Chan KY, Ng PC, Li K, Leung TF, Leung KT ( 2016 )
Refereed conference paper presented and published in conference proceedings
Phase 1/2 safety and antitumor activity of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (HCC): interim analysis of the CheckMate-040 dose escalation study. J Clin Oncol 34, 2016 (suppl; abstr 4012)
EI-KHOUEIRT B Anthony, SANGRO Bruno, YAU Thomas Cheung, CROCENZI S Todd, WELLING III Theodore Hobart, YEO Winnie, CHOPRA Akhil, ANDERSON Jeffrey, DELA CRUZ Christine Marie, LANG Lixin, NEELY Jaclyn, MELERO Ignacio ( 2016 )
Refereed conference paper presented and published in conference proceedings
Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC
MA Buig Yue Brigette, RUDIN M Charles, CERVANTES Andres, DOWLATI Afshin, COSTA Dainel, SCHMID Peter, HEIST Rebecca, VILLAFLOR M Victoria, SARKAR Indrani, HUSENI A Mahrukh, FOSTER Paul, O HEAR Carol, GETTINGER Scott, BESSE Benjamin ( 2016 )
Refereed conference paper presented and published in conference proceedings
R4 RGS subfamily proteins negatively regulates SDF-1/CXCR4 signaling in CD34+ hematopoietic stem and progenitor cells
Kam Tong Leung, Yorky Tsin Sik Wong, Karen Li, Kathy Yuen Yee Chan, Xiao-Bing Zhang, Ting Fan Leung, Pak Cheung Ng, Chi Kong Li ( 2016 )
Refereed conference paper presented and published in conference proceedings
Safety, clinical activity and biomarker results from a Phase Ib study of erlotinib plus atezolizumab in advanced NSCLC
RUDIN M Charles, CERVANTES Andres, DOWLATI Afshin, BESSE Benjamin, MA Buig Yue Brigette, COSTA Danniel, SCHMID Peter, HEIST Rebecca, VILLAFLOR Victoria, SARKAR Indrani, HUSENI Mahrukh, FOSTER Paul ( 2016 )
Refereed conference paper presented and published in conference proceedings
A formulation of 4D treatment planning for tumor tracking volumetric modulated arc therapy for lung cancer. (TU-F-CAMPUS-J-01)
CHEUNG Michael, LEE Louis, CHAN Anthony Tak Cheung ( 2015 )
AAPM 2015, 57th Annual Meeting and Exhibition of the American Association Of Physicists In Medicine
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1118/1.4925821
A Phase II Clinical Trial on Combined Axitinib And Transarterial Chemoembolization (TACE) For Hepatocellular Carcinoma (HCC): Final Results And Evaluation of Clinical Predictor For Response
CHAN Lam Stephen, YEO Winnie, MO Kwok Fai, LI Leung, LEE Kit Fai, CHAN Wing Hung Anthony, HUI Edwin P, LAI Bo San Paul, MOK Shu Kam Tony, CHAN Anthony Tak Cheung, YU Chun Ho ( 2015 )
2015 ASCO Annual Meeting
Refereed conference paper presented and published in conference proceedings
A Phase II Study of Axitinib in Patients With Recurrent Or Metastatic Nasopharyngeal Carcinoma (NPC)
HUI Edwin P, MA Buig Yue Brigette, MO Kwok Fai, KAM Koon Ming Michael, CHAN Lam Stephen, LOONG Herbert Ho Fung, LEUNG Sing Fai, KING D Ann, WANG Ki, AHUJA Anil Tejbhan, CHAN Charles M L, HUI Wun Chun, WONG Chi Hang, CHAN Anthony Tak Cheung ( 2015 )
2015 ASCO Annual Meeting
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1200/jco.2015.33.15_suppl.6031
Association between early tumor shrinkage (ETS) and outcomes in RAS-wild type (WT) patients (pts) with metastatic colorectal cancer (mCRC) receiving first-line
CHENG A, CORNELIO G, SHEN L, PRICE T, YANG T, CHUNG I, DAI G, LIN J, SHARMA A, YEH K H, MA Buig Yue Brigette, ZAATAR A, GUAN Z, MASOOD N, SRIMUNIMMIMIT V, YAU T, BEIER F, CHATTERJEE S, LIM R ( 2015 )
ASCO 2015, 51st Annual Meeting of American Society Of Clinical Oncology
Refereed conference paper presented and published in conference proceedings
Chemotherapeutic Drug, Paclitaxel, Induces the Key Molecular Determinants of Immunogenic Cell Death in Ovarian Cancer
LAU Tat San, CHAN Kit Ying Loucia, WONG Chi Hang, CHEUNG Tak Hong, YIM So Fan, LEE Ho Sze Jacqueline, CHUNG Kwok Hung Tony, KWONG Joseph ( 2015 )
Cancer, Inflammation, and Immunity
Refereed conference paper presented and published in conference proceedings
Effects of regorafenib therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial
SHUKUI Q, KIM T W, YAU T, MA Buig Yue Brigette, PAN H, XU J, BAI Y, CHI Y, WANG L, YEH L H, BI F, CHENG Y, LE A T, LIN J K, LIU T, MA D, KAPPELER C, CHANG J, XU R, JIN L ( 2015 )
2015 Gastrointestinal Cancers Symposium
Refereed conference paper presented and published in conference proceedings
Fast analytical beamlet optimization for volumetric intensity-modulated arc therapy (#SU-E-T-422)"
CHAN Kenny, LEE Louis, XING L, CHAN Anthony Tak Cheung ( 2015 )
AAPM 2015, 57th Annual Meeting and Exhibition of the American Association Of Physicists In Medicine
Refereed conference paper presented and published in conference proceedings

10 | 25 | 50 | 100

1/9

Research Outputs (433)

Share Link

Our policy towards the use of cookies